N H Kim1, V Nadithe1, M Elsayed1, O M Merkel2. 1. Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, United States. 2. Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, United States ; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, United States.
Abstract
Upon activation, T cells of various subsets are the most important mediators in cell-mediated immune responses. Activated T cells play an important role in immune system related diseases such as chronic inflammatory diseases, viral infections, autoimmune disease, transplant rejection, Crohn disease, diabetes, and many more. Therefore, efforts have been made to both visualize and treat activated T cells specifically. This review summarizes imaging approaches and selective therapeutics for activated T cells and gives an outlook on how tracking and treating can be combined into theragnositc agents for activated T cells.
Upon activation, T cells of various subsets are the most important mediators in cell-mediated immune responses. Activated T cells play an important role in immune system related diseases such as chronic inflammatory diseases, viral infections, n>an class="Disease">autoimmune disease, transplant rejection, Crohn disease, diabetes, and many more. Therefore, efforts have been made to both visualize and treat activated T cells specifically. This review summarizes imaging approaches and selective therapeutics for activated T cells and gives an outlook on how tracking and treating can be combined into theragnositc agents for activated T cells.
Entities:
Keywords:
Activated T cells; Imaging; Targeting; Theragnostics; Treatment; siRNA
Authors: Ana Batista; João T Barata; Elke Raderschall; Stephen E Sallan; Nadia Carlesso; Lee M Nadler; Angelo A Cardoso Journal: Exp Hematol Date: 2011-01-26 Impact factor: 3.084
Authors: Calogero D'Alessandria; Valentina di Gialleonardo; Marco Chianelli; Stephen J Mather; Erik F J de Vries; Francesco Scopinaro; Rudi A Dierck; Alberto Signore Journal: Mol Imaging Biol Date: 2009-12-01 Impact factor: 3.488
Authors: Jordan M White; Outi M Keinänen; Brendon E Cook; Brian M Zeglis; Heather M Gibson; Nerissa T Viola Journal: Mol Pharm Date: 2020-05-12 Impact factor: 4.939
Authors: Yuran Xie; Na Hyung Kim; Venkatareddy Nadithe; Dana Schalk; Archana Thakur; Ayşe Kılıç; Lawrence G Lum; David J P Bassett; Olivia M Merkel Journal: J Control Release Date: 2016-03-19 Impact factor: 9.776